Overall | SOF/VEL | GLE/PIB | ||||
---|---|---|---|---|---|---|
Total | 7,338 | 467 | 6,871 | |||
DDIs: Contraindication (Red) | 115 | 1.6% | 0 | 0.0% | 115 | 1.7% |
DDIs: Potential clinically significant interaction (Amber) | 2337 | 31.8% | 276 | 59.1% | 2061 | 30.0% |
DDIs: weak interaction (Yellow) | 1367 | 18.6% | 1 | 0.2% | 1366 | 19.9% |
No DDIs | 3519 | 48.0% | 190 | 40.7% | 3329 | 48.5% |